Hedge Fund - Biotechnology Value Fund / BVF Inc
Moonlake Immunotherapeutics ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $1,313,560,041 | 32.87% | 21,751,284 | $ |
| 2 | 2023 - Q3 (2023-09-30) | $1,239,823,188 | 33.43% | 21,751,284 | $ |
| 3 | 2023 - Q2 (2023-06-30) | $1,109,315,484 | 30.91% | 21,751,284 | $ |
| 4 | 2023 - Q1 (2023-03-31) | $465,259,965 | 17% | 21,751,284 | $ |
| 5 | 2022 - Q4 (2022-12-31) | $228,388,482 | 9.63% | 21,751,284 | $ |
| 6 | 2022 - Q3 (2022-09-30) | $173,140,000 | 7.15% | 21,751,284 | $ |
| 7 | 2022 - Q2 (2022-06-30) | $114,194,000 | 5.51% | 21,751,284 | $ |
The displayed share prices are average quarterly stock market prices.